知識產(chǎn)權(quán)
國外發(fā)明專利29項
| 序號 | 專利名稱 | 中文名稱 | 專利號 | 公開(公告)日 | 應(yīng)用領(lǐng)域 |
| 美國 | |||||
| 1 | Preparation containing chlorogenic acid crystal form and use thereof | 一種包含綠原酸晶型的制劑及其用途 | US10314806B2 | 2019/6/11 | 核心工藝 |
| 2 | Crystalline form of chlorogenic acid and preparation method thereof |
一種綠原酸晶型及其制備方法 |
US10246401B2 |
2019/4/2 |
核心工藝 |
| 3 | Method for preparation of pharmaceutically acceptable chlorogenic acid |
一種藥用綠原酸的制備方法 |
US10189769B2 |
2019/1/29 |
核心工藝 |
| 4 | Chlorogenic acid powder-injection and preparation method thereof |
一種綠原酸粉針劑及其制備方法 |
US9918956B2 |
2018/3/20 |
核心工藝 |
| 5 | Chlorogenic acid-containing composition for nasal administration |
一種含綠原酸的鼻腔給藥組合物 |
US11596598B2 |
2023/3/7 |
劑型 |
| 6 | Application of chlorogenic acid and compositions thereof in preparation of drugs for treating squamous cell carcinoma | 綠原酸及其組合物在制備治療鱗狀細(xì)胞癌的藥物中的用途 | US12194013B2 | 2025/1/14 | 腫瘤 |
| 7 | Pharmaceutical composition and use thereof in preparing drug for treating tumor multi-drug resistance | 一種藥物組合物及其在制備治療腫瘤多藥耐藥性的藥物中的用途 | US12178792B2 | 2024/12/31 | 腫瘤 |
| 8 | Pharmaceutical composition for treating kidney cancer and application thereof | 用于治療腎癌的藥物組合物及其應(yīng)用 | US12156861B2 | 2024/12/3 | 腫瘤 |
| 9 | Use of chlorogenic acid composition thereof in preparation of medicament for treating sarcoma | 綠原酸及其組合物在制備治療肉瘤的藥物中的用途 | US12150926B2 | 2024/11/26 | 腫瘤 |
| 10 | Medicine for combined use in cancer treatment | 一種治療癌癥的聯(lián)合用藥物（綠原酸和激素類藥物） | US11628199B2 | 2023/4/18 | 腫瘤 |
| 11 | Use of chlorogenic acid in preparation of drug for treating chordoma | 綠原酸在制備治療脊索瘤的藥物中的用途 | US11547715B2 | 2023/1/10 | 腫瘤 |
| 12 | Use of chlorogenic acid in preparing pharmaceuticals for treatment of LAG-3-mediated disease | 綠原酸在制備治療以LAG-3為靶點的疾病的藥物中的用途 | US11135160B2 | 2021/10/5 | 腫瘤 |
| 13 | Method and medicines for treating melanoma | 綠原酸在制備治療黑色素瘤的藥物中的用途及治療黑色素瘤的藥物 | US10265289B2 | 2019/4/23 | 腫瘤 |
| 14 | Pharmaceutical composition, preparation method therefor and use thereof | 一種藥物組合物及其制備方法和用途 | US10238702B2 | 2019/3/26 | 腫瘤 |
| 15 | Uses of chlorogenic acid in the preparation of medicaments for treatment of oligodendroglioma |
綠原酸在制備治療少突膠質(zhì)瘤的藥物中的用途 |
US10004713B2 |
2018/6/26 |
腫瘤 |
| 16 | Drug combination for treatment of amyotrophic lateral sclerosis, preparation method and use thereof | 一種用于治療肌萎縮性脊髓側(cè)索硬化癥的聯(lián)合用藥組合物及其制備方法和用途 | US11376267B2 | 2022/7/5 | 罕見病 |
| 17 | Application of chlorogenic acid in preparing medicines for treating lupus erythematosus | 綠原酸在制備治療紅斑狼瘡的藥物中的用途 | US10058525B2 | 2018/8/28 | 免疫 |
| 18 | Uses of chlorogenic acid in the preparation of medicaments for treatment of psoriasis |
綠原酸在制備治療銀屑病的藥物中的用途 |
US9884036B2 |
2018/2/6 | 免疫 |
| 19 | Uses of chlorogenic acid in preparation of drug for preventing and treating ocular inflammation |
綠原酸在制備防治眼部炎癥的藥物中的用途 |
US12364677B2 |
2025/7/22 |
其它疾病 |
| 歐洲 | |||||
| 20 |
Preparation of a crystalline form of chlorogenic acid |
一種綠原酸晶型及其制備方法 |
EP3141540B1 |
2021/3/3 |
核心工藝 |
| 21 | Preparation method for medicinal chlorogenic acid |
一種藥用綠原酸的制備方法 |
EP3225615B1 |
2020/1/8 |
核心工藝 |
| 22 | Application of chlorogenic acid in preparing medicines for treating lupus erythematosus | 綠原酸在制備治療紅斑狼瘡的藥物中的用途 | EP3257507B1 | 2025/1/8 | 免疫 |
| 23 | Use of chlorogenic acid in preparation of drug treating psoriasis | 綠原酸在制備治療銀屑病的藥物中的用途 | EP3199151B1 | 2020/9/23 | 免疫 |
| 24 | Use of chlorogenic acid in preparing medicine or pharmaceutical composition for preventing or treating pain | 綠原酸在制備預(yù)防或治療疼痛的藥物或藥物組合物中的用途 | EP3909576B1 | 2023/11/15 | 其它疾病 |
| 日本 | |||||
| 25 | 薬用クロロゲン酸の調(diào)製方法 | 一種藥用綠原酸的制備方法 | JP6488379B2 | 2019/3/20 | 核心工藝 |
| 26 | 杜仲葉からクロロゲン酸を抽出する方法 | 一種從杜仲葉中提取綠原酸的方法 | JP6473803B2 | 2019/2/20 | 核心工藝 |
| 27 | 原料クロロゲン酸又は原薬クロロゲン酸とその調(diào)製方法及び質(zhì)量検出方法 | 一種綠原酸原料或原料藥及其制備方法和質(zhì)量檢測方法 | JP6379286B2 | 2018/8/22 | 核心工藝 |
| 韓國 | |||||
| 28 | ????? ??? ? ?? ?? ?? | 一種綠原酸晶型及其制備方法 | KR101893964B1 | 2018/8/31 | 核心工藝 |
| 澳大利亞 | |||||
| 29 | Use of chlorogenic acid in preparing medicine or pharmaceutical composition for preventing or treating pain |
綠原酸在制備預(yù)防或治療疼痛的藥物或藥物組合物中的用途 |
AU2020206399B2 |
2025/4/17 |
其它疾病 |